Psoriasis and psoriatic arthritis are exacerbated by interferon alfa and other treatments for
hepatitis C virus infection. Immunosuppressants and hepatotoxic drugs are relatively …

The treatment of severe psoriasis in patients with concomitant hepatitis-C virus infection is
quite difficult because several systemic anti-psoriatic drugs are contraindicated owing to …

Accumulated data suggest that etanercept may be a therapeutic option in patients with
hepatitis C and coexisting autoimmune disorders such as rheumatoid arthritis, psoriasis …

Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic
challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic …

To the Editor: A 53-year-old Russian man was under our care for severe long-standing
psoriasis (37 years) and psoriatic arthritis mutilans (17 years) of the hands requiring …

We report a case of a 49 year-old male who had undergone liver transplant due to hepatitis
C, Laennec's cirrhosis, and hepatocellular carcinoma, and was treated with etanercept for …

High levels of tumor necrosis factor-alpha (TNF-alpha) are associated with hepatitis C virus
(HCV) infection and all stages of human immunodeficiency virus (HIV) infection. TNF-alpha …

Objective. The treatment of the rheumatological manifestations associated with hepatitis C
virus (HCV) remains difficult. To examine the safety of anti-tumour necerosis factor-α …

The introduction in recent years of biologic medicines has greatly changed the treatment of
psoriasis and psoriatic arthropathy (PsA). These drugs have been effective in the treatment …

A 45-year-old woman with chronic hepatitis C was treated with peginterferon alpha-2b in
combination with ribavirin, which activated psoriasis. In the patient, psoriasis reoccurred …